These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12459525)

  • 1. Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo.
    Dreno B; Moyse D
    Eur J Dermatol; 2002; 12(6):549-52. PubMed ID: 12459525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis.
    Langtry JA; Rowland Payne CM; Staughton RC; Stewart JC; Horrobin DF
    Clin Exp Dermatol; 1997 Sep; 22(5):216-9. PubMed ID: 9536541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial.
    Rigopoulos D; Ioannides D; Kalogeromitros D; Gregoriou S; Katsambas A
    Br J Dermatol; 2004 Nov; 151(5):1071-5. PubMed ID: 15541087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is metronidazole 0.75% gel effective in the treatment of seborrhoeic dermatitis? A double-blind, placebo controlled study.
    Ozcan H; Seyhan M; Yologlu S
    Eur J Dermatol; 2007; 17(4):313-6. PubMed ID: 17540638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a randomized, double-blind, vehicle-controlled efficacy trial of pimecrolimus cream 1% for the treatment of moderate to severe facial seborrheic dermatitis.
    Warshaw EM; Wohlhuter RJ; Liu A; Zeller SA; Wenner RA; Bowers S; Schultz JC; Katz HI; McCormick CL; Parneix-Spake A
    J Am Acad Dermatol; 2007 Aug; 57(2):257-64. PubMed ID: 17188780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
    Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
    Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
    Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
    Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of seborrhoeic dermatitis of the scalp with a topical solution of urea, lactic acid, and propylene glycol (K301): results of two double-blind, randomised, placebo-controlled studies.
    Emtestam L; Svensson Å; Rensfeldt K
    Mycoses; 2012 Sep; 55(5):393-403. PubMed ID: 21966947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis.
    Koc E; Arca E; Kose O; Akar A
    J Dermatolog Treat; 2009; 20(1):4-9. PubMed ID: 18677657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial.
    Kim TW; Mun JH; Jwa SW; Song M; Kim HS; Ko HC; Kim MB; Song KH; Lee SK; Seo JK; Lee D; Kim BS
    Acta Derm Venereol; 2013 Sep; 93(5):557-61. PubMed ID: 23388687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An investigator-blind, randomized, 4-week, parallel-group, multicenter pilot study to compare the safety and efficacy of a nonsteroidal cream (Promiseb Topical Cream) and desonide cream 0.05% in the twice-daily treatment of mild to moderate seborrheic dermatitis of the face.
    Elewski B
    Clin Dermatol; 2009; 27(6 Suppl):S48-53. PubMed ID: 19878781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study.
    Dreno B; Chosidow O; Revuz J; Moyse D;
    Br J Dermatol; 2003 Jun; 148(6):1230-6. PubMed ID: 12828753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lithium gluconate 8% in the treatment of seborrheic dermatitis].
    Dréno B; Blouin E; Moyse D
    Ann Dermatol Venereol; 2007 Apr; 134(4 Pt 1):347-51. PubMed ID: 17483754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study.
    Seckin D; Gurbuz O; Akin O
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):345-50. PubMed ID: 17309456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic dermatitis.
    Squire RA; Goode K
    J Dermatolog Treat; 2002 Jun; 13(2):51-60. PubMed ID: 12060502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
    Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
    J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
    Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
    Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial.
    Esfandiarpour I; Ekhlasi A; Farajzadeh S; Shamsadini S
    J Dermatolog Treat; 2009; 20(1):14-8. PubMed ID: 18608735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.